Chemotherapy-induced lung disease

Research output: Contribution to journalReview articlepeer-review

135 Scopus citations


The lung has significant susceptibility to injury from a variety of chemotherapeutic agents. The clinician must be familiar with classic chemotherapeutic agents with well-described pulmonary toxicities and also must be vigilant that a host of new agents may exert emerging adverse effects on lung function. The diagnosis of chemotherapy-associated lung disease remains an exclusionary process, particularly with respect to usual and atypical infections as well as recurrence of the underlying neoplastic process in these immunocompromised patients. In many instances, chemotherapy-associated lung disease may respond to withdrawal of the offending agent and to the judicious application of corticosteroid therapy in selected patients.

Original languageEnglish (US)
Pages (from-to)53-64
Number of pages12
JournalClinics in Chest Medicine
Issue number1
StatePublished - Mar 1 2004

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Chemotherapy-induced lung disease'. Together they form a unique fingerprint.

Cite this